Pet Pharm Biotech Co., Ltd. (TPEX:7762)
Taiwan · Delayed Price · Currency is TWD 84.30
+3.40 (4.20%)
At close: Sep 19, 2025
Pet Pharm Biotech Market Cap
Pet Pharm Biotech has a market cap or net worth of 4.34 billion as of September 19, 2025. Its market cap has increased by 185.76% in one year.
Market Cap
4.34B
Enterprise Value
3.94B
Revenue
159.02M
Ranking
n/a
PE Ratio
206.65
Stock Price
84.30
Market Cap Chart
Since July 26, 2024, Pet Pharm Biotech's market cap has increased from 1.39B to 4.34B, an increase of 211.54%. That is a compound annual growth rate of 168.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 19, 2025 | 4.34B | 161.97% |
| Dec 31, 2024 | 1.66B | 18.92% |
| Jul 26, 2024 | 1.39B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Taiwan Semiconductor Manufacturing Company | 33.32T |
| Hon Hai Precision Industry | 2,986.40B |
| MediaTek | 2,406.73B |
| Delta Electronics | 2,317.01B |
| Fubon Financial Holding | 1,206.68B |
| Quanta Computer | 1,077.34B |
| Chunghwa Telecom | 1,039.50B |
| Cathay Financial Holding | 953.50B |